In 1982, NIAID scientist Willy Burgdorfer, Ph.D., identified the bacterium that causes Lyme disease. Read about the groundbreaking discovery of Borrelia burgdorferi.
Volunteer for NIAID-funded clinical studies related to Lyme disease on ClinicalTrials.gov.
Lyme disease, or borreliosis, is caused by the bacterium Borrelia burgdorferi and is transmitted to humans through the bite of an infected blacklegged deer tick. It is the most common tickborne infectious disease in the United States. State health departments reported 27,203 confirmed cases and 9,104 probable cases of Lyme disease to the Centers for Disease Control and Prevention in 2013.
NIAID has a long-standing commitment to conduct Lyme disease research with the major goals of developing better means of diagnosing, treating, and preventing the disease. To accomplish these objectives, the NIAID Lyme disease research portfolio includes a broad range of activities designed to increase our understanding of this disease. Learn more about NIAID Lyme disease research.
Test for Persistent Lyme Infection Using Live Ticks Shown Safe in Clinical Study—Feb. 12, 2014
HHS Federal Research Update on Lyme Disease Diagnostics—Sept. 24, 2012
NIAID Media Availability: NIH-Funded Scientists Sequence Genomes of Lyme Disease Bacteria—Oct. 18, 2010
All Tickborne Diseases News Releases
News From NIAID-Supported Institutions
Last Updated December 16, 2014